Compare HCA Health Inc (HCA) vs Tyson Foods, Inc. (TSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Tyson Foods, Inc. — how do they compare? HCA Health Inc trades at $443.69 (market cap $95.08B), while Tyson Foods, Inc. trades at $52.31 (market cap $18.19B). The key difference: HCA Health Inc is far larger — about 5.2× Tyson Foods, Inc.'s market cap, and Tyson Foods, Inc. pays the higher dividend (3.95%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Tyson Foods, Inc. for 76 Days on average.
| HCA | TSN | |
|---|---|---|
Market Cap | $95.08B | $18.19B |
Volume | 998,787 | 3,320,883 |
Sector | Health | Consumer Staples |
52-Week High | $545.13 | $68.75 |
52-Week Low | $361.32 | $50.47 |
Typical Hold Time | 76 Days | 76 Days |
Enterprise Value | $145.62B | $25.45B |
Dividend Yield | 0.71% | 3.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $445.01, up 2.96% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.6B in 2025, with net income of $6.78B, and the stock trades at a P/E of 14.73. Analyst consensus is a Buy with a $461.12 price target, though ongoing legal investigations pose a headwind.
The outlook remains positive given solid demand and cost controls, but risks include payer-mix pressure and high debt levels. Upside potential exists if earnings growth continues, but investors should monitor legal developments and interest rate impacts on the leveraged balance sheet.
Tyson Foods (TSN) trades at $52.34, up 0.71% with mixed technical signals showing neutral momentum. The company reported Q2 2026 EPS of $0.99 beating expectations, but faces margin pressure with net income margin at 1.03%. Recent news highlights dividend stability despite beef segment losses and ongoing securities investigations. Cash flow trends show operational strength with $2.16B from operations in 2025, though net cash flow remains negative.
The stock presents a value opportunity with P/S of 0.33 below industry averages, supported by 53% analyst buy ratings and $65.40 consensus target. However, margin compression, beef segment challenges, and legal investigations create near-term headwinds. Long-term prospects depend on operational improvements and successful navigation of current business challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Tyson Foods, Inc.
Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.
Read more on TSN →
